Cook Inc. Launches First U.S. Device For Secondary Endovascular Intervention

Bloomington, Ind. - The Zenith® Renu™ AAA Ancillary Graft from Cook Inc., the first medical device specifically designed for secondary endovascular intervention in patients having received prior endovascular repair of infrarenal abdominal aortic aneurysms, has received U.S. Food and Drug Administration approval for sale, Cook announced today.

The device, which has successfully treated a significant number of AAA patients in Europe and Australia since 2002, will be available to U.S. physicians beginning next month.

"Our U.S. introduction of Renu confirms Cook's commitment to treating aneurysms and other life-threatening conditions along the entire aorta," said Barry Thomas, global leader of Cook's endovascular therapy productions division. "This new graft demonstrates a significant advance in medical device technology to help a particular cohort of patients."

This industry-unique device is available in two configurations, a main body extension and a converter. The Renu AAA Ancillary Graft has been engineered to treat migrations in either Dacron or ePTFE membrane-based aortic endografts, Thomas said.

Like all the Zenith AAA Endovascular Graft main body components, the Renu AAA Ancillary Graft utilizes an uncovered suprarenal stent with anchoring barbs to provide strong proximal fixation and enhanced graft-to-vessel sealing. Its lightweight, strong, shrink-resistant woven synthetic polyester graft material is the same that has been used in all Zenith endografts from Cook.

The new Renu graft system uses Cook's proven Flexor® Introducer System that features a kink-resistant, hydrophilic delivery sheath. A trigger-wire system facilitates accurate placement, controlled release and stabilization of the ancillary endograft during deployment, while the system's Captor® Hemostatic Valve inhibits blood reflux.

For more information on the Zenith Renu AAA Ancillary Graft from Cook Incorporated, visit www.zenithstentgraft.com.

The world's largest privately held manufacturer of medical devices with international headquarters in Bloomington, Ind., COOK® (www.cookmedical.com/) is a leading designer, manufacturer and global distributor of minimally invasive medical device technology for diagnostic and therapeutic procedures. Since its founding in 1963, Cook has created innovative technologies for drug-eluting and bare metal stents, aortic and vascular endografts, catheters, wire guides, introducer needles and sheaths, embolization coils, medical biomaterials, vena cava filters and other minimally invasive medical devices for radiology, cardiology, urology and OB/GYN, critical care medicine, surgery, gastroenterology, bone access and endovascular therapies.

MEDIA CONTACT:
David McCarty
Director of Public Relations
Cook Incorporated - 812-339-2235 ext. 2387
Email: dmccarty@cook-inc.com

Back to Previous Page